Search by Drug Name or NDC

NDC 63090-0340-30 NUPLAZID 34 mg/1 Details

NUPLAZID 34 mg/1

NUPLAZID is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Acadia Pharmaceuticals Inc.. The primary component is PIMAVANSERIN TARTRATE.

MedlinePlus Drug Summary

Pimavanserin is used to treat hallucinations and delusions in people with psychosis from Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance). Pimavanserin is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.

Related Packages: 63090-0340-30
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Pimavanserin

Product Information

NDC	63090-0340
Product ID	63090-340_02c10e00-7f20-41ea-ad45-b239c8b7098a
Associated GPIs	59400028200120
GCN Sequence Number	078605
GCN Sequence Number Description	pimavanserin tartrate CAPSULE 34 MG ORAL
HIC3	H8Y
HIC3 Description	SELECTIVE SEROTONIN 5-HT2A INVERSE AGONISTS (SSIA)
GCN	44963
HICL Sequence Number	043373
HICL Sequence Number Description	PIMAVANSERIN TARTRATE
Brand/Generic	Brand
Proprietary Name	NUPLAZID
Proprietary Name Suffix	n/a
Non-Proprietary Name	pimavanserin tartrate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	34
Active Ingredient Units	mg/1
Substance Name	PIMAVANSERIN TARTRATE
Labeler Name	Acadia Pharmaceuticals Inc.
Pharmaceutical Class	Atypical Antipsychotic [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA210793
Listing Certified Through	2024-12-31

Package

NDC 63090-0340-30 (63090034030)

Pricing Information	N/A
NDC Package Code	63090-340-30
Billing NDC	63090034030
Package	30 CAPSULE in 1 BOTTLE, PLASTIC (63090-340-30)
Marketing Start Date	2018-06-28
NDC Exclude Flag	N